Pandemic has caused perfect storm for MedTech

Accenture (ACN) Announces Strategic Investment in Geneyx

Fund commits to $350M dedicated LS investments

Industry insiders recount top medtech wins of 2021

Bridging the ESG Valley of Death

Breakthrough science and the future of venture capital

European Biotech Investors Cap Off Record Year in Fundraising

UBS clients raise $650 mln for biggest yet biotech impact fund

Experts predict massive growth in health tech

Exscientia : Announces Closing of $510.4 Million Aggregate Financing, Consisting of $350.4 Million Upsized Initial Public Offering With Full Exercise of Underwriters' Option to Purchase Additional ADSs and $160.0 Million Concurrent Private Placement